• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Biotech HOLDRs

Biotech HOLDRs

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Publicis Groupe Statement

    Publicis Groupe Statement

  2. Publicis Groupe: Notification of Share Buyback Transactions

    Publicis Groupe: Notification of Share Buyback Transactions

  3. Funds That Buy Like Buffett, 2017

    These funds follow the Oracle of Omaha in buying and holding quality businesses.

  4. Publicis Groupe announces the appointment of Céline Fronval as Groupe General Counsel

    Publicis Groupe announces the appointment of Céline Fronval as Groupe General Counsel

  5. BBH Stays Unhedged With New Global Fund

    BBH Global Core Select manager Tim Hartch avoids currency hedging so he can eliminate complexities in managing the portfolio and maintain a focus on stable underlying businesses.

  6. Timothy Hartch and Michael Keller, BBH Core Select

    Skittish about stocks? The managers of BBH Core Select have carefully constructed a 30-name portfolio that has been more stable than the market.

  7. Hartch: BBH Fund Closure Protecting Against Future Flows

    BBH Core Select comanager Tim Hartch and his team recently closed the fund to better manage the strategy through organic growth than though the anticipated inflows.

  8. BBH's Core Focus on Google

    By homing in on Google's core revenue-generating operations, BBH manager Tim Hartch sees a value proposition in the online firm, with Google's other investments being gravy.

  9. Publicis Groupe: 2016 Annual Financial Report Available

    Publicis Groupe: 2016 Annual Financial Report Available

  10. Publicis Groupe: 2016 Dividend

    Publicis Groupe: 2016 Dividend

12345

©2017 Morningstar Advisor. All right reserved.